Immunotherapeutic gene transfer into muscle

Trends Immunol. 2001 Mar;22(3):149-55. doi: 10.1016/s1471-4906(00)01822-6.

Abstract

Immuno-gene therapy can be advantageously performed with nonviral approaches. Genes that encode regulatory cytokines or inflammatory cytokine inhibitors can be delivered intramuscularly and expressed for weeks or months. This type of gene transfer into muscle has been shown to ameliorate several autoimmune diseases and is relevant to the development of effective DNA vaccines in autoimmune diseases, infectious diseases and cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antigen Presentation
  • Autoimmunity / immunology
  • Complement System Proteins / immunology
  • Cytokines / genetics
  • Cytokines / immunology
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / prevention & control
  • Gene Transfer Techniques*
  • Genetic Therapy / methods
  • Humans
  • Immune Tolerance / immunology
  • Immunotherapy / methods*
  • Injections, Intramuscular
  • Lupus Vulgaris / immunology
  • Lupus Vulgaris / therapy
  • Muscle, Skeletal*
  • Vaccines, DNA / administration & dosage

Substances

  • Cytokines
  • Vaccines, DNA
  • Complement System Proteins